Does HLA type predispose some individuals to cancer?

Molecular Medicine Today

Volumn 5, Issue 8, 1999, Pages 337-342

  Little, Ann Margaret ^a   Stern, Peter L ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B27 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOTYPE; ANKYLOSING SPONDYLITIS; BURKITT LYMPHOMA; CANCER SUSCEPTIBILITY; CELIAC DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HLA TYPING; HODGKIN DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSURVEILLANCE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL CARCINOMA; NASOPHARYNX CARCINOMA; NATURAL KILLER CELL; PROTEIN DEGRADATION; REVIEW; RHEUMATOID ARTHRITIS; T CELL LEUKEMIA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

HEPATITIS B VIRUS; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPES; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0032819415     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(99)01524-5     Document Type: Note

References (35)

1. Bodmer, J.G. et al. (1999) Nomenclature for factors of the HU system, 1998, Eur. J. Immunogenet. 26, 81-116
2. Mellman, L.Turley, S.J.andSteinman, P.M. (1998) Antigen processing for amateurs and professionals, Trends CellBiol. 8, 231-237
3. Matzinger, P. (1994) Tolerance, danger and the extended family, Annu. Rev. Immunol. 12, 991-1045
4. Brewerton, D.A. et al. (1973) Ankyloslng spondylitis and HLA-A27, Lancet 1, 904-907
5. Lôpez-Larrea, C., Gonzalez, S. and MartînezBarra, J. (1998) The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy, Mol. Med. Today 4, 540-550
6. Parham, P. (1996) Presentation of HLA class Iderived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis, Immunol. Rev. 154, 137-154
7. Hall, F.C. and Bowness, P. (1996) HLA and disease: from molecular function to disease association? in HLA andMHC: Genes, Molecules and Function (Browning, M. and McMichael, A., eds), pp. 353-381, BIOS Scientific Publishers
8. Nelson, J.L et al. (1992) Rheumatoid Arthritis, in HLA 1991 (Vol. 1) (Tsuji, K. etal., eds) pp. 772-774, Oxford University Press
9. Dessen, A. et al. (1997) X-ray crystal structure of HLA-DR4 (DRA'0101, DRBT0401) complexed with a peptide from human collagen II, Immunity 7, 473-181
10. Auger, I., Escola, J.M., Gorvel, J.P. and Roudier, J. (1996) HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins, Nat. Med. 2, 306-310
11. Caillat-Zucman, S. etal. (1997) Insulin dependent diabetes mellitus (IDDM): 12th International histocompatibility workshop study, in Genetic Diversity of HLA, Functional and Medical Implication (Vol. 1) (Charron, D., ed.) pp. 389-398, EDK
12. Hall, M.A. etal. (1992) Coeliac disease study, in HLA 1991 (Vol. 1) (Tsuji, K. etal., eds) pp. 722-729, Oxford University Press
13. Sjostrom, H. et al. (1998) Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-ceil recognition, Scand. J. Immunol. 48, 111-115
14. Bach, E.A., Aguet, M. and Schreiber, R.D. (1997) The IFN gamma receptor: a paradigm for cytokine receptor signaling, Annu. Rev. Immunol. 15, 563-591
15. Mandruzzato. S. etal. (1997) ACASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma, J. Exp. Med. 186, 785-793
16. Scanlan, M.J. etal. (1998) Characterization of human colon cancer antigens recognized by autologous antibodies, Int. J. Cancer 76, 652-658
17. Hicklin D.J., Marincola, RM. and Ferrone, S. (1999) HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story, Mol. Med. Today 5, 178-186
18. Garrido, F. et al. (1997) Implications for immunosurveillance of altered HLA class I phenotypes In human tumors, Immunol. Today, 18, 89-95
19. Tomlinson, I. and Bodmer, W. (1999) Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog, Nat. Med. 5, 11-12
20. Weidenfeld, E.A., Fernandez-Vinas, M., Berzofsky, J.A. and Carbone, O.P. (1994) Evidence for selection against human lung cancers bearing p53 missense mutations which occur with HLAA 0201 peptide consensus motif, Cancer Res. 54, 1175-1177
21. Eeles, R.A., Ponder, B.A.J., Easton, D.F. and Norwich, A., eds (1996) Genetic Predisposition to Cancer, Chapman and Hall
22. Pisani, P., Parkin, D.M., Munoz, N. and Ferlay, J. (1997) Cancer and infection: estimates of the attributable fraction in 1990, Cancer Epidemiol. Biomarkers Prev. 6, 387-400
23. Hengel, H. and Koszinowski, U.H. (1997) Interference with antigen processing by viruses, Curr.'Opin. Immunol. 9, 470-476
24. Sonoda, S. et al. (1997) HU and HTLV: 12th international histocompatibility workshop study, in HLA Genetic Diversity of HLA Functional and Medical Implication (Vol. I) (Charron, D., ed.) pp. 429-436, EDK
25. White, J.D. et al. (1996) Distribution of human leukocyte antigens in a population of black patients with human T-cell lymphotrophic virus type l-associated adult T-cell leukemia/lymphoma, Cancer Epidemiol. Biomarkers Prev. 5, 873-877
26. Manns, A. et al. (1998) Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult Tcell leukemia/lymphoma in a black population, J. Nail. Cancer Inst. 90, 617-622
27. McDermott, A.B. et al. (1997) Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination, Tissue Antigens 50, 8-14
28. Almarri, A. and Batchelor, J.R. (1994). HLA and hepatitis B infection, Lancet 344, 1194-1195
29. Thursz, M.R. e/aJ.(1995) Association between an MHC class-ll allele and clearance of hepatitis-B virus in the Gambia, New Engl. J. Med. 332, 1065-1069
30. Jones, E.H., Biggar, R.J., Nkrumah, F.K. and Lawler, S.D. (1985) HLA-DR7 association with African Burkitt-lymphoma, Hum. Immunol. 13, 211-217
31. Bodmer, J. etal. (1992) Hodgkin's disease study, in HLA 1991 (Vol. 1) (Tsuji, K. et al., eds) pp. 701-705, Oxford University Press
32. Chan, S.H. et al. (1986) Nasopharyngeal carcinoma: joint report, in HLA in Asia-Oceania (Aizawa, M., ed.) pp. 396-400, Hokkaido University Press
33. Burt, R.D. et al. (1994) A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians, Int. J, Cancer 56, 465-467
34. Stern, P.L (1996) Immunity to human papillomavirus associated cervical neoplasia, Adv. Cancer Res. 69, 175-211
35. Jeffery, K.J.M. etal. (1999) HLA alleles determine human T-lymphotropic (HTLV-I) proviral load and the risk of HTLV-I associated myelopathy, Proc. Natl. Acad. Sci. U. S. A. 96, 3848-3853